Orion Portfolio Solutions’s BioMarin Pharmaceuticals BMRN Stock Holding History

Orion Portfolio Solutions’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-13,083	Closed	-$1.08M	–	1787
2024 Q2	$1.08M	Sell	13,083 -6,534	-33%	-$544K	0.01%	957
2024 Q1	$1.71M	Sell	19,617 -568	-3%	-$50.8K	0.02%	732
2023 Q4	$2M	Sell	20,185 -2,150	-10%	-$190K	0.02%	630
2023 Q3	$1.98M	Buy	22,335 +3,785	+20%	+$337K	0.02%	614
2023 Q2	$1.61M	Sell	18,550 -1,029	-5%	-$96.8K	0.02%	748
2023 Q1	$1.9M	Buy	+19,579	New	+$2.03M	0.02%	615
2020 Q3	–	Sell	-226	Closed	-$28K	–	626
2020 Q2	$28K	Sell	226 -104	-32%	-$10.3K	﹤0.01%	854
2020 Q1	$28K	Buy	330 +19	+6%	+$1.64K	﹤0.01%	735
2019 Q4	$26K	Buy	+311	New	+$23.5K	﹤0.01%	707

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Orion Portfolio Solutions's BMRN Position: Q3 2024 in Review

Orion Portfolio Solutions sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2024, closing a stake of 13,083 shares — an estimated $1.08M sold.

Orion Portfolio Solutions first reported a position in BMRN in Q4 2019 and held it in 9 quarters. The position peaked at $2M in Q4 2023. 553 funds tracked by Wall St. Rank hold BMRN as of Q3 2024.

Orion Portfolio Solutions reported no remaining BioMarin Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Orion Portfolio Solutions sold 13,083 BioMarin Pharmaceuticals shares in Q3 2024, an estimated $1.08M.
Orion Portfolio Solutions first reported a position in BioMarin Pharmaceuticals in Q4 2019 and held it in 9 quarters.
Orion Portfolio Solutions's BioMarin Pharmaceuticals position peaked at $2M in Q4 2023.
553 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2024.

Based on Orion Portfolio Solutions's 13F filing for Q3 2024, filed 15 Nov 2024.